We transform Australia & New Zealand's most exciting biomedical research discoveries into new medical products that improve patient outcomes and save lives.

Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.

Learn more about who we are
CUREator is an Australian national biotechnology incubator supporting the development of pre-clinical and clinical stage medical innovation.

Portfolio

We’re immensely proud of our portfolio. Partnering with talented scientists, clinicians and entrepreneurs, we have supported more than 50 companies to date.

Vaxxas
Vaxxas

Vaxxas' proprietary Nanopatch™ technology is a needle-free vaccine delivery solution

View Project
CatalYm
CatalYm

Reversing GDF-15-mediated immunosupression to induce anti-tumour responses

View Project
Entact Bio
Entact Bio

Developing a new class of therapeutics that enhance the function of beneficial proteins

View Project
Developing disease-modifying mitochondrial therapeutics for neurodegenerative disorders
Developing disease-modifying mitochondrial therapeutics for neurodegenerative disorders

View Project
Pheon Therapeutics
Pheon Therapeutics

Developing first-in-class ADCs to treat cancer

View Project
TamoRx
TamoRx

Developing novel immuno-oncology small molecule inhibitors

View Project
Amaroq Therapeutics
Amaroq Therapeutics

Targeting long non-coding RNAs for next generation cancer therapies

View Project
Currus Biologics
Currus Biologics

Developing the next generation of CAR-T cell therapies to treat solid cancers

View Project
See all

Members

Brandon BioCatalyst brings together more than 50 leading medical research institutes across Australia and New Zealand.

Institute
The Centenary Institute of Cancer Medicine and Cell Biology

The Centenary Institute is a world-leading independent medical research institute, closely affiliated to the University of Sydney and the Royal Prince Alfred Hospital. Our research focuses on three key areas: cancer, inflammation and cardiovascular disease. Our strength lays in uncovering disease mechanisms and applying this knowledge to improve diagnostics and treatments for patients.

View
Institute
St Vincent’s Institute of Medical Research

SVI is an independent medical research institute that conducts research into the cause, prevention and treatment of diseases that are common and have serious effects on health. We strive, through our research, to help alleviate the enormous financial, emotional and physical impacts of these diseases on individuals, their families and the community.

View
Institute
Australian Institute for Bioengineering and Nanotechnology

The University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN) is an integrated multi-disciplinary research institute bringing together the skills of world-class researchers in the areas of bioengineering and nanotechnology.

View

Membership

Brandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.

Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.

Learn more